BLRX
Price
$1.51Alerts
Change
+$0.04 (+2.72%)
Updated
Nov 11 closing price
Capitalization
8.56M
11 days until earnings call
Intraday BUY SELL Signals
IKT
Price
$1.63Alerts
Change
+$0.08 (+5.16%)
Updated
Nov 11 closing price
Capitalization
209.3M
140 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BLRX vs IKT

BLRX vs IKT Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
BLRX vs. IKT commentary
Nov 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLRX is a Buy and IKT is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for BLRX with price predictions
Nov 11, 2026

BLRX's RSI Indicator stays in oversold zone for 6 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 11 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +5.97% 3-day Advance, the price is estimated to grow further. Considering data from situations where BLRX advanced for three days, in 194 of 246 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.

BLRX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for BLRX turned negative on November 04, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In 40 of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BLRX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for BLRX entered a downward trend on November 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 55 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.622) is normal, around the industry mean (3.498). P/E Ratio (0.000) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (7.868) is also within normal values, averaging (440.869).

The Tickeron Price Growth Rating for this company is 89 (best 1 - 100 worst), indicating slightly worse than average price growth. BLRX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BLRX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

A.I.Advisor
a Summary for IKT with price predictions
Nov 11, 2026

IKT's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for IKT turned positive on October 29, 2026. Looking at past instances where IKT's MACD turned positive, the stock continued to rise in 42 of 47 cases over the following month. The odds of a continued upward trend are 89%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where IKT's RSI Oscillator exited the oversold zone, 32 of 38 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 84%.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 60 of 73 cases where IKT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 82%.

The Momentum Indicator moved above the 0 level on November 11, 2026. You may want to consider a long position or call options on IKT as a result. In 83 of 93 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 89%.

Following a +16.67% 3-day Advance, the price is estimated to grow further. Considering data from situations where IKT advanced for three days, in 192 of 229 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.

IKT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IKT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.

The Aroon Indicator for IKT entered a downward trend on November 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 28 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.365) is normal, around the industry mean (3.498). P/E Ratio (-3.409) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (440.869).

The Tickeron Seasonality Score of 44 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 76 (best 1 - 100 worst), indicating slightly worse than average price growth. IKT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IKT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

FUNDAMENTALS RATINGS
BLRX vs IKT: Fundamental Ratings
BLRX
IKT
OUTLOOK RATING
1..100
6411
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
28
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9798
PRICE GROWTH RATING
1..100
8976
P/E GROWTH RATING
1..100
10098
SEASONALITY SCORE
1..100
5044

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IKT's Valuation (28) in the null industry is in the same range as BLRX (55) in the Pharmaceuticals Other industry. This means that IKT’s stock grew similarly to BLRX’s over the last 12 months.

IKT's Profit vs Risk Rating (100) in the null industry is in the same range as BLRX (100) in the Pharmaceuticals Other industry. This means that IKT’s stock grew similarly to BLRX’s over the last 12 months.

BLRX's SMR Rating (97) in the Pharmaceuticals Other industry is in the same range as IKT (98) in the null industry. This means that BLRX’s stock grew similarly to IKT’s over the last 12 months.

IKT's Price Growth Rating (76) in the null industry is in the same range as BLRX (89) in the Pharmaceuticals Other industry. This means that IKT’s stock grew similarly to BLRX’s over the last 12 months.

IKT's P/E Growth Rating (98) in the null industry is in the same range as BLRX (100) in the Pharmaceuticals Other industry. This means that IKT’s stock grew similarly to BLRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BLRXIKT
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
84%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
N/A
Bullish Trend 1 day ago
89%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
89%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 23 days ago
79%
Bullish Trend 3 days ago
84%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 9 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
86%
Aroon
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
86%
COMPARISON
Comparison
Nov 12, 2026
Stock price -- (BLRX: $1.51 vs. IKT: $1.55)
Brand notoriety: BLRX and IKT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BLRX: 37% vs. IKT: 86%
Market capitalization -- BLRX: $8.56M vs. IKT: $209.3M
BLRX [@Biotechnology] is valued at $8.56M. IKT’s [@Biotechnology] market capitalization is $209.3M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $138.67B. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BLRX’s FA Score shows that 0 FA rating(s) are green while IKT’s FA Score has 1 green FA rating(s).

  • BLRX’s FA Score: 0 green, 5 red.
  • IKT’s FA Score: 1 green, 4 red.
According to our system of comparison, IKT is a better buy in the long-term than BLRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BLRX’s TA Score shows that 4 TA indicator(s) are bullish while IKT’s TA Score has 5 bullish TA indicator(s).

  • BLRX’s TA Score: 4 bullish, 3 bearish.
  • IKT’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, IKT is a better buy in the short-term than BLRX.

Price Growth

BLRX (@Biotechnology) experienced а -19.47% price change this week, while IKT (@Biotechnology) price change was +4.73% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.49%. For the same industry, the average monthly price growth was -6.84%, and the average quarterly price growth was -13.86%.

Reported Earning Dates

BLRX is expected to report earnings on Nov 23, 2026.

IKT is expected to report earnings on Nov 13, 2026.

Industries' Descriptions

@Biotechnology (-0.49% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

BLRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BLRX has been loosely correlated with IKT. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if BLRX jumps, then IKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLRX
1D Price
Change %
BLRX100%
+2.72%
IKT - BLRX
43%
Loosely correlated
+5.16%
PYXS - BLRX
37%
Loosely correlated
+0.61%
XLO - BLRX
35%
Loosely correlated
-0.70%
DWTX - BLRX
33%
Loosely correlated
-4.07%
KURA - BLRX
33%
Loosely correlated
+2.11%
More

IKT and

Correlation & Price change

A.I.dvisor indicates that over the last year, IKT has been loosely correlated with MLYS. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if IKT jumps, then MLYS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IKT
1D Price
Change %
IKT100%
+5.16%
MLYS - IKT
42%
Loosely correlated
+4.12%
VIR - IKT
41%
Loosely correlated
-0.15%
SLDB - IKT
41%
Loosely correlated
+6.00%
EDIT - IKT
40%
Loosely correlated
-4.99%
CABA - IKT
40%
Loosely correlated
N/A
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EXPD194.595.40
+2.85%
Expeditors International of Washington
ICU1.920.02
+1.05%
SeaStar Medical Holding Corporation
DOUG1.740.01
+0.58%
Douglas Elliman
PXED19.13-0.09
-0.47%
Phoenix Education Partners Inc
MMS65.38-0.74
-1.12%
MAXIMUS